Mark S. Levine, General Counsel at Flexion Therapeutics Inc (FLXN), sold 734 shares at $12.36 ($9K) on 2019-01-03, disclosed to the SEC on 2019-01-04.
Scheduled sale ($9k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |